“…Further, administration of the thrombin inhibitor, Refludan, Ò before injury, protected systemic platelet responses to ADP indicating a potential role for thrombin in the regulation of systemic platelet dysfunction after TBI. 15 In the current study, we correlated temporal changes in ADPand AA-induced platelet activation, as measured by TEG PM, with altered expression of coagulation markers TF, fibrin(ogen), and P-selectin in the rat brain after injury. In all three markers, the extent of localized expression of these proteins inversely correlated with systemic platelet responses to ADP and AA agonists, potentially supporting the hypothesis that there is an immediate but recoverable systemic exhausted platelet effect.…”